Abstract:Abstract Background High density lipoprotein (HDL) exerts various atheroprotective functions including cholesterol efflux capacity (CEC). HDL can attenuate lipid burden at atherosclerotic lesion by CEC. Based on the HDL`s role for moderate atherosclerosis, HDL-cholesterol level which indicates the amount of HDL has been evaluated to assess the risk of cardiovascular disease (CVD). Nevertheless, many clinical studies demonstrated that HDL-cholesterol level does not always reflect the risk of CVD, and CEC which represents the quality of HDL is considered as surrogate biomarker for CVD. CEC is prospective biomarker for CVD risk assessment, however, CEC measurement encounters barriers for clinical application because of its requirements of cultured cell and radioactive substance for conventional CEC assay. To overcome these problems, we invented a novel CEC assay called immobilized liposome-bound gel beads (ILG) method. This method is cell-free assay and utilizes a fluorescence substance as cholesterol tracer. Although the ILG method is useful assay for clinical application, previous study revealed that bilirubin caused false positive error on CEC value. Hence, current ILG method might produce incorrect CEC evaluation for patients with hyperbilirubinemia and even healthy subjects within the range of biological variation of bilirubin. In this study, we improved the influence of bilirubin for ILG method by using bilirubin oxidase (BOD). Methods BOD (Asahi Kasei Corp.) was added to 10 mM Tris-HCl (pH 7.4) containing 150 mM of NaCl and 1 mM of Na2EDTA (Buffer A). Bilirubin from ‘Interference check A Plus’ (Sysmex Inc.) was added to serum (free-: 10 mg/dL, conjugated-:9.7 mg/dL), and apoB-depleted serum (BDS) was derived from the bilirubin additive serum using polyethylene glycol. After the prepared bilirubin additive BDS was incubated with BOD-containing Buffer A for 16 h, the absorbance spectrum was analyzed. In addition, the time course of bilirubin decrement was monitored during 16 h-incubation. We further measured the fluorescence intensity of bilirubin additive BDS incubated with BOD-containing Buffer A. Using the newly developed BOD-containing Buffer A for ILG method, CEC of bilirubin additive serum was evaluated. Finally, we measured CEC of 4 healthy individuals by conventional and the improved ILG method. The CEC value was standardized by fluorescence intensity of reference sample which was measured in every assay. Results BOD contained in Buffer A could convert bilirubin to biliverdin from results of absorbance spectrum. According to the time course of bilirubin decrement, both free- and conjugated-bilirubin were oxidized to biliverdin in approximately 6 h. By converting bilirubin to biliverdin, fluorescence light was weakened greatly. We confirmed that there was no significant difference of CEC values between non bilirubin-additive serum and bilirubin additive serum. Compared healthy individual CEC values measured by conventional and improved ILG method, all subjects showed significant decrease of CEC values from the improved method, and false positive error caused by bilirubin was ameliorated. Conclusion In this study, we achieved to improve the positive error caused by bilirubin on CEC assay using ILG method. This improvement would contribute to more accurate CEC assessment by ILG method and advance the clinical application of this method.

The Effects of Icteric Discoloration and Lipemia of Various Concentrations on Enzymatic Method for Determing Serum Potassium

A quality control procedure for central venous blood sampling based on potassium concentrations

Comparison of the Results of Potassium & Sodium Determining in Mixed Serum by Different Electrochemistry Measurements

A-209 Application of Bilirubin Oxidase for Improvement of False Positive Error Caused by Bilirubin on Cholesterol Efflux Capacity Assay by Immobilize Liposome-Bound Gel Beads method

Disposable Blood Potassium Sensors Based on Screen-Printed Thick Film Electrodes

B-127 The Effect of Hemolysis on Potassium Measurement in a Community Setting: The Marching Error

The determination of potassium concentration in vitreous humor by low pressure ion chromatography and its application in the estimation of postmortem interval.

Effects of different specimen pretreatment methods on the measurement of thyrotropin stimulating hormone in serum

Accurate correction model of blood potassium concentration in hemolytic specimens

Indirect Determination of Potassium Calcium and Magnesium in Blood Plasma by High Performance Capillary Electrophoresis with UV-Detection

Lipemia Interferences in Biochemical Tests, Investigating the Efficacy of Different Removal Methods in comparison with Ultracentrifugation as the Gold Standard

Is There a Risk of Misinterpretation of Potassium Concentration from Undetectable Hemolysis Using a POCT Blood Gas Analyzer in the Emergency Department?

Verifying the nonreporting hemolysis index for potassium, phosphate, magnesium, AST, LDH, iron, CA 19-9, and vitamin D, using Beckman Coulter AU5800 and DxI800 automated analyzers

Low-cost, syringe based ion-selective electrodes for the evaluation of potassium in food products and pharmaceuticals

Evaluation of serum electrolytes measurement through the 6-year trueness verification program in China

Comparison of Methods in Determining Serum LDL-C in Diabetic Patients

Trueness assessment of routine electrolytes measuring systems using the candidate reference method by ion chromatography

Influence of Different Interfering Ions on Determination of Serum Chlorine by Various Ion-Selective Electrodes

Calibration solutions for the simultaneous potentiometric measurement of sodium, potassium and calcium in blood plasma: examination of the electrochemical factors affecting precision and accuracy in direct potentiometric clinical analysers

Content Determination of Potassium,Sodium,Calcium and Magnesium in Kabiven PI by ICP-AES

Potential medical impact of unrecognized in vitro hypokalemia due to hemolysis: a case series